Form4insider filings, from the source

SEC Form 4 · accession 0001720702-18-000002

Arcus Biosciences, Inc. · RCUS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Tim Kutzkey
10% Owner
Period of report
Mar 19, 2018
Accepted (ET)
Mar 19, 2018 · 2:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001724521

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Mar 19, 2018C1,767,676—A1,767,676D
Common StockF1,F2Mar 19, 2018C875,087—A2,642,763D
Common StockF1,F2Mar 19, 2018C427,660—A3,070,423D
Common StockF1,F3Mar 19, 2018C470,427—A470,427D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF2,F1—Mar 19, 2018C1,767,676D——Common Stock1,767,6760D
Series B Preferred StockF2,F1—Mar 19, 2018C875,087D——Common Stock2,642,7630D
Series C Preferred StockF2,F1—Mar 19, 2018C427,660D——Common Stock3,070,4230D
Series C Preferred StockF3,F1—Mar 19, 2018C470,427D——Common Stock470,4270D

Explanation of responses